Cargando…
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
BACKGROUND: The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data suggest that the tyrosine-kinase inhibitor imatinib reverses pulmonary capillary leak. METHODS: This randomised, double-blind, placebo-contro...
Ejemplares similares
-
How do medical specialists value their own intercultural communication behaviour? A reflective practice study
por: Paternotte, E., et al.
Publicado: (2016) -
Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors
por: Kampshoff, C. S., et al.
Publicado: (2018) -
Pulmonary granulocyte influx and impaired alveolar macrophage adenylyl cyclase responsiveness in developing respiratory distress
por: Amsterdam, J. G. C. van, et al.
Publicado: (1993) -
Feline Lymphoma: Patient Characteristics and Response Outcome of the COP-Protocol in Cats with Malignant Lymphoma in The Netherlands
por: Versteegh, Hannah, et al.
Publicado: (2023) -
Effects of eggshell temperature pattern during incubation on primary immune organ development and broiler immune response in later life
por: Wijnen, H.J., et al.
Publicado: (2020)